Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy

Convalescent Plasma (CP) is a form of adaptive immunization. It is an indirect way to protect a susceptible individual by providing immunity against a specific pathogen. Currently, the outbreak of highly infectious respiratory illness, i.e., novel coronavirus (COVID-19), has so far affected 2,471,136 individuals and has caused 169,006 deaths (WHO situation report-93; April 22, 2020). The USA alone reported 695,353 infected cases with the highest number of fatalities (n  = 37,602). The outbreak is so dangerous that it has affected the entire world (213 countries/areas/territories).
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Source Type: research